Biotech Values

[bladerunner1717]

The counter argument would be:

'Of course, "Verification of manufacturing purity is a regular feature of generic-drug applications..." but not by way of "in vitro immunogenicity data." The FDA was clearly looking for data on safety and efficacy.'


Bladerunner